Telomerase‐specific T‐cells kill pancreatic tumor cells in vitro and in vivo
Jan Schmidt, Angela Märten(Boehringer Ingelheim (United States)), Eduard Ryschich(Heidelberg University), Markus W. Büchler(Heidelberg University), Elisabeth Sievers(Karolinska University Hospital), I G Schmidt-Wolf(Stanford University)
Cited by 19
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k